O Picard - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

O Picard

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Lancet (London, England)|March 26, 1983

Acquired immunodeficiency syndrome in FranceJ B Brunet, E Bouvet, J Leibowitch, et al.

Alimentary Pharmacology & Therapeutics|November 19, 2016

Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumabB Ungar, U Kopylov, T Engel, et al.

Alimentary Pharmacology & Therapeutics|April 20, 2016

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitisB Ungar, Y Mazor, R Weisshof, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Lancet (London, England)|March 26, 1983

Acquired immunodeficiency syndrome in FranceJ B Brunet, E Bouvet, J Leibowitch, et al.

Alimentary Pharmacology & Therapeutics|November 19, 2016

Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumabB Ungar, U Kopylov, T Engel, et al.

Alimentary Pharmacology & Therapeutics|April 20, 2016

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitisB Ungar, Y Mazor, R Weisshof, et al.

Pageof 8